Stockreport

OptimizeRx: How The Stock Is Changing Pharma Marketing [Seeking Alpha]

OptimizeRx Corporation  (OPRX) 
NASDAQ:AMEX Investor Relations: optimizerx.com/investors
PDF Q2 2025 financials show strong revenue growth, improved margins, and a shift to higher-margin subscription revenues, supporting management's raised guidance for 2025. [Read more]